Assessment and Plan for Community-Acquired Pneumonia
How do you assess a patient with community-acquired pneumonia?
Start with a thorough history and physical examination. Ask about symptoms like cough, fever, and shortness of breath. Check for risk factors such as smoking or recent respiratory infections. On exam, listen for crackles or decreased breath sounds.
Order a chest X-ray to confirm the diagnosis. Blood tests like a CBC can help assess the severity. Sputum cultures aren't always needed but consider them in severe cases or if the patient isn't improving.
What should the treatment plan include?
Your plan should focus on antibiotics, supportive care, and follow-up.
- Antibiotics: For outpatients without comorbidities, consider amoxicillin or doxycycline. If the patient has comorbidities, use a combination like amoxicillin-clavulanate with a macrolide or monotherapy with a respiratory fluoroquinolone.
- Supportive Care: Recommend rest, hydration, and over-the-counter medications for fever and pain. Advise on smoking cessation if applicable.
- Follow-up: Schedule a follow-up in 48-72 hours to check for clinical improvement. If the patient isn't improving, reassess and consider further testing or hospitalization.
When should you consider hospitalization?
Use tools like the CURB-65 score to assess the need for hospitalization. Hospitalize if the patient has confusion, uremia, respiratory rate over 30, low blood pressure, or is over 65. Severe cases may need ICU care.
What are some real-world examples of CAP management?
Consider a 45-year-old smoker with a cough, fever, and crackles on exam. A chest X-ray shows a right lower lobe infiltrate. You start oral amoxicillin and schedule a follow-up in two days. Another case might be a 70-year-old with diabetes. Here, you might choose a fluoroquinolone due to comorbidities and age, and recommend close monitoring.
Sources
- Reyes LF, Conway Morris A, Serrano-Mayorga C. Community-acquired pneumonia.. Lancet (London, England) (2025). PMID: 41110447.
- Jones BE, Ramirez JA, Oren E. Diagnosis and Management of Community-acquired Pneumonia: An Official American Thoracic Society Clinical Practice Guideline.. American journal of respiratory and critical care medicine (2026). PMID: 40679934.
- Dinh A, Lebeaux D. Duration of antibiotic treatment for community-acquired pneumonia.. Infectious diseases now (2025). PMID: 40749837.
- REMAP-CAP Investigators, Angus DC. Effect of hydrocortisone on mortality in patients with severe community-acquired pneumonia : The REMAP-CAP Corticosteroid Domain Randomized Clinical Trial.. Intensive care medicine (2025). PMID: 40261382.